XETRA - Delayed Quote EUR

Carl Zeiss Meditec AG (AFX.DE)

97.00 -0.65 (-0.67%)
As of 11:49 AM GMT+2. Market Open.
Loading Chart for AFX.DE
DELL
  • Previous Close 97.65
  • Open 96.20
  • Bid 96.90 x 18700
  • Ask 97.10 x 15000
  • Day's Range 96.00 - 97.70
  • 52 Week Range 72.60 - 126.00
  • Volume 20,908
  • Avg. Volume 132,356
  • Market Cap (intraday) 8.676B
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) 31.29
  • EPS (TTM) 3.10
  • Earnings Date May 8, 2024
  • Forward Dividend & Yield 1.10 (1.13%)
  • Ex-Dividend Date Mar 22, 2024
  • 1y Target Est 154.33

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

4,823

Full Time Employees

September 30

Fiscal Year Ends

Recent News: AFX.DE

Performance Overview: AFX.DE

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AFX.DE
0.02%
DAX PERFORMANCE-INDEX
5.85%

1-Year Return

AFX.DE
20.11%
DAX PERFORMANCE-INDEX
11.64%

3-Year Return

AFX.DE
31.31%
DAX PERFORMANCE-INDEX
14.69%

5-Year Return

AFX.DE
25.82%
DAX PERFORMANCE-INDEX
45.07%

Compare To: AFX.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AFX.DE

Valuation Measures

As of 4/18/2024
  • Market Cap

    8.73B

  • Enterprise Value

    8.88B

  • Trailing P/E

    31.50

  • Forward P/E

    32.36

  • PEG Ratio (5yr expected)

    3.58

  • Price/Sales (ttm)

    4.17

  • Price/Book (mrq)

    4.04

  • Enterprise Value/Revenue

    4.24

  • Enterprise Value/EBITDA

    21.63

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.22%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    13.24%

  • Revenue (ttm)

    2.09B

  • Net Income Avi to Common (ttm)

    276.8M

  • Diluted EPS (ttm)

    3.10

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.6M

  • Total Debt/Equity (mrq)

    7.16%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: AFX.DE

Analyst Price Targets

105.00
154.33 Average
97.00 Current
195.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

People Also Watch